Hostname: page-component-cb9f654ff-rkzlw Total loading time: 0 Render date: 2025-09-10T01:07:55.734Z Has data issue: false hasContentIssue false

Specific learning difficulties and intelligence in children with RASopathies. The Grey Matter project

Published online by Cambridge University Press:  26 August 2025

F. Castellano-García
Affiliation:
Universidad Cardenal Herrera-CEU, CEU Universities
B. Moliner-Castellano
Affiliation:
Private Center Specialized in Neurodevelopmental Disorders, Castellón de la Plana
J. Arias-Álvarez
Affiliation:
GOA Center, Oviedo
B. Villar-Baptista
Affiliation:
Consejería de Educación de Madrid, Madrid
L. Solbes-Gálvez
Affiliation:
CREAS. Espacio de desarrollo y aprendizaje, El Campello, Alicante
M. Moreno-Ventura
Affiliation:
CREAS. Espacio de desarrollo y aprendizaje, El Campello, Alicante
D. M. Peñalver-García
Affiliation:
University of Murcia, Murcia
E. Fernández-Jiménez*
Affiliation:
Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital Hospital La Paz Institute for Health Research (IdiPAZ), Madrid Faculty of Social Sciences and Communication, Universidad Europea de Madrid, Villaviciosa de Odón, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Children with Noonan syndrome, the most prevalent RASopathy, exhibit a characteristic neurocognitive phenotype. Specific difficulties in learning, memory, and executive function are among the most frequently observed manifestations documented in the scientific literature.

Objectives

The present study aimed to measure specific learning difficulties and intelligence in children with RASopathies.

Methods

A total sample of 47 patients (55.3% male) aged 3–16 years (M = 8.6, S.D. = 3.1) was recruited from various Spanish regions (Murcia, Alicante, Gandía, Valencia, Castellón de la Plana, Tarragona, Cantabria, Asturias, Zaragoza, Madrid, Badajoz, Huelva, Sevilla and Cádiz), within the framework of The Grey Matter project. Most patients were diagnosed with Noonan syndrome, and some had Cardiofaciocutaneous syndrome. The most frequent mutations were PTPN11 (72.3%), RIT1 (6.4%), and unknown mutations in 12.8% of patients. Patients were assessed using the Spanish version of the Wechsler Preschool and Primary Scale of Intelligence, Fourth Edition (WPPSI-IV) or the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V) according to age; the Spanish Reading Processes Evaluation Battery (PROLEC) according to the appropriate age range (from 6 years); and the Spanish Writing Processes Evaluation Battery (PROESC), from 8 years.

Results

On the one hand, 32.3% presented with severe difficulty in reading words. In turn, 30% of the children showed severe difficulty in reading comprehension of texts when they were read by an examiner, and 29% after reading by themselves. On the other hand, 56% of the children presented severe orthographic difficulty in writing words and 50% presented severe difficulty in written expressions. Finally, regarding intelligence, the mean total IQ of the children was 84.7 points (S.D. = 15.1), with better scores on the Verbal Comprehension Index (M = 89.4; S.D. = 16), Visual Spatial Index (M = 87.7; S.D. = 13.8), and Fluid Reasoning Index (M = 88.6; S.D. = 11.9), in contrast with the Working Memory Index (M = 84.3; S.D. = 13.2), and the Processing Speed Index (M = 83.2; S.D. = 14.4). In turn, 42.6% of children had low global intelligence scores (IQ ≤ 79).

Conclusions

In conclusion, children with RASopathies, particularly those diagnosed with Noonan syndrome, need educational support to compensate for all these significant academic difficulties.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.